Developing an innovative, patented rapid in vitro diagnostic (IVD) test to detect nosocomial diseases. More specifically, the aim is to develop a new rapid Point-Of-Care (POC) predictive diagnostic test to discriminate healthcare-acquired fungal infections from other causes of infections.
Leading provider of antimicrobial drug development support services for clients around the world. IHMA provides a full suite of technical capabilities and domain expertise in all phases of antimicrobial drug development: drug discovery, clinical development, regulatory approval and commercialization.
ImmunSkills SA is a company active in the field of cell therapy. Its objective is to improve the effectiveness of treatments for solid cancers by developing a new product based on allogenic cells.
Inflamalps is a company that develops new substances capable of fighting certain inflammatory diseases of the eye and in particular dry eye disease and uveitis.
The company JLR Project is specialized in clean room controls and equipment qualification.
Medabe is active in consulting, research and training in the fields of health, safety and work organization, as well as in related fields (support to companies, employees and institutions in the field of medical prevention). It also provides workplace analysis services and develops health software solutions.
Researches and develops applications of Novochizol, a unique chitosan nanoparticle technology that yields different carriers of small molecules, peptides, nucleic acids and proteins for sustained, localized delivery to any living tissue, with intracellular targeting potential.
Orio Therapeutics is developing an innovative technology that modifies therapeutic proteins to improve delivery through controlled localization for increased efficacy and reduced dose. Today, Orio Therapeutics is focused on developing therapies for patients with myocardial infarction. However, it remains capable of modifying any protein-based therapy with its technology
BioArk is a technology site dedicated to biotechnologics and life sciences. It’a a place committed to the life science industry.
Brain Core is developing a new type of intelligence – Vortial Intelligence (VI) – aimed at increasing the skills of humans and machines, in a benevolent perspective.
Sion Site
Rue de l’Industrie 23
CH-1950 Sion
Tél. +41 (0) 58 332 21 20
info@bioark.ch
Monthey Site
Rte de l’Ile-au-bois 1A
CH-1870 Monthey
Tél. +41 (0) 58 332 21 20
info@bioark.ch
Massimo Nobile
| BioArk | Intranet BioArk Monthey
